Navigation Links
Navinta LLC is Pleased to Announce US FDA Approval of Sodium Ferric Gluconate Injection in Sucrose [a generic equivalent of Ferrlecit® Injection by Sanofi Aventis] Based on Its Proprietary Technology
Date:3/31/2011

EWING, N.J., March 31, 2011 /PRNewswire/ -- Navinta's proprietary complex pharmaceutical ingredient, Sodium Ferric Gluconate as covered under Navinta's US Patent 7,179,939 and US Drug Master File is a key component in the recent approval of GeneraMedix Inc.'s ANDA for Sodium Ferric Gluconate Complex in Sucrose Injection, 62.5 mg/5 mL.    

The Navinta's proprietary complex pharmaceutical ingredient technology provides a platform for preparation of complex injectable formulations of Iron drug products.

"We are pleased to see commercialization of our innovative complex pharmaceutical product," said Dr. Mahendra Patel, Chief Executive Officer of Navinta, LLC. "Our work represents the culmination of many years of laboratory and drug development work. Navinta's development pipe line targets several such complex molecules in their development portfolio."

About Navinta

Navinta, LLC in Ewing, N.J. is a technology driven Pharmaceutical Company that focuses on novel routes of synthesis of new and existing drug molecules, complex pharmaceutical ingredients, novel formulations of liquid dosage form, novel oral dosage form, novel injectable dosage form and implantable drug delivery devices. Navinta has currently at least fifteen (15) patents granted or pending with the United States Patent and Trademark Office.


'/>"/>
SOURCE Navinta LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Shanghai ChemPartner Is Pleased to be Part of Agios Groundbreaking Cancer Research
2. MedNet Solutions Announces the Release of iMedNet EDC
3. Syndax Pharmaceuticals Announces Entinostat Data at 102nd Annual American Association for Cancer Research Meeting
4. Fueling Interventional Radiology Growth: SIR Foundation Announces Navilyst Medical Pledge
5. Telik Announces Presentation and Webcast at 10th Annual Needham Healthcare Conference
6. AAIPharma Services Announces Compendial Testing Facility Expansion
7. Qmed Announces Increase in Dedicated Staff as Part of Development Plans for 2011
8. BioMed Realty, L.P. Announces Closing of Offering of 3.85% Senior Unsecured Notes Due 2016
9. VHGI Holdings, Inc. Announces Expansion of Sun Gold Project
10. Regeneron Announces Presentation at the 10th Annual Needham Healthcare Conference
11. Merz Pharmaceuticals Announces New Centers for Medicare and Medicaid Billing Q-Code for Xeomin® (incobotulinumtoxinA)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... BOCA RATON, Fla. , Dec. 5, ... Commercialization of Public Research (the Florida Institute) ... agreement SegAna, LLC, an Orlando ... Central Florida. The Florida Institute supports new company ... funding gaps for companies spinning out of Florida-based universities ...
(Date:12/5/2016)... Dec. 5, 2016  Breckenridge Pharmaceutical, Inc. announced ... marketing agreement with development and manufacturing partner Gland ... the terms of this agreement, Breckenridge will market ... the United States . The ... ANDA. The products cover a wide range of ...
(Date:12/5/2016)... 2016  Sharn Anesthesia Inc. announced today that it ... partner for Salter Labs.  The company also received the ... of outstanding sales performance. Salter Labs is ... care, including the market gold standard ECO 2 ... of the Parker Flex-Tip® Endotracheal Tube, which is a ...
Breaking Medicine Technology:
(Date:12/5/2016)... Atlanta, GA (PRWEB) , ... ... ... information technology and security executive networking and relationship-marketing firm, announced today that ... for the 2017 Information Security Executive® (ISE®) Central Awards. , Awards include ...
(Date:12/5/2016)... ... December 05, 2016 , ... “Epilepsy Awareness,” which can ... 6th, sparks a conversation about epilepsy, bearing down on the social stigma and ... be diagnosed with epilepsy within their lifetime. With such a large percentage of ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... announced that the company will provide alerting technology to Central Illinois Health ... awarded $1.7 million in federal funds as the sole sub-recipient participating with ...
(Date:12/5/2016)... ... December 05, 2016 , ... Dr. Barry M. Weintraub, one of New ... recently participated in the 36th Annual Cutting Edge Aesthetic Symposium at the Waldorf Astoria ... getting that perfect, yet natural-looking, nose. Dr. Weintraub, who is world-renowned for his expertise ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... for the Florida Hospital West Florida Region. McGuinness brings experience in executive leadership ... engaging staff, physicians and leaders. , In her new role, that officially begins ...
Breaking Medicine News(10 mins):